Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP308913.RAjjThGfp42CHKtTRE0Wl0iEdP0-IRK2D6cZzJtfS9SaI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP308913.RAjjThGfp42CHKtTRE0Wl0iEdP0-IRK2D6cZzJtfS9SaI130_assertion type Assertion NP308913.RAjjThGfp42CHKtTRE0Wl0iEdP0-IRK2D6cZzJtfS9SaI130_head.
- NP308913.RAjjThGfp42CHKtTRE0Wl0iEdP0-IRK2D6cZzJtfS9SaI130_assertion wasGeneratedBy ECO_0000203 NP308913.RAjjThGfp42CHKtTRE0Wl0iEdP0-IRK2D6cZzJtfS9SaI130_provenance.
- NP308913.RAjjThGfp42CHKtTRE0Wl0iEdP0-IRK2D6cZzJtfS9SaI130_assertion wasDerivedFrom befree-20150227 NP308913.RAjjThGfp42CHKtTRE0Wl0iEdP0-IRK2D6cZzJtfS9SaI130_provenance.
- NP308913.RAjjThGfp42CHKtTRE0Wl0iEdP0-IRK2D6cZzJtfS9SaI130_assertion SIO_000772 20518885 NP308913.RAjjThGfp42CHKtTRE0Wl0iEdP0-IRK2D6cZzJtfS9SaI130_provenance.
- NP308913.RAjjThGfp42CHKtTRE0Wl0iEdP0-IRK2D6cZzJtfS9SaI130_assertion evidence source_evidence_literature NP308913.RAjjThGfp42CHKtTRE0Wl0iEdP0-IRK2D6cZzJtfS9SaI130_provenance.
- NP308913.RAjjThGfp42CHKtTRE0Wl0iEdP0-IRK2D6cZzJtfS9SaI130_assertion description "[In the majority of the matched pairs, the diagnoses between EUS-FNA and surgical specimens were concordant using the following criteria: neuroendocrine markers negative, CK7 positive, and mutated KRAS gene for invasive ductal carcinomas; neuroendocrine markers diffusely positive, CK7 and CDX2 negative, and wild-type KRAS gene for well-differentiated endocrine tumors; and neuroendocrine markers no more than focal positive, CK7 and CDX2 with various staining patterns, and wild-type KRAS gene for acinar cell carcinomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP308913.RAjjThGfp42CHKtTRE0Wl0iEdP0-IRK2D6cZzJtfS9SaI130_provenance.